Contact us
All conditions
English
English简体中文繁體中文TürkçeEspañolBahasa MelayuBahasa IndonesiaTiếng ViệtPortuguêsРусский
All condition topics/Lung cancer

Lung cancer
Treatment options in Shanghai

Explore whether specialist assessment in Shanghai could help you start treatment sooner, consider more options, or preserve more healthy lung tissue.

Explore treatment options See hospital expertise
Treatment choices, eligibility and timing require an individual assessment by the hospital's clinical team.
Editorial illustration for “NSCLC Molecular Reports: Preparing a Treatment Review in Shanghai”
Lung cancer
Move toward treatment soonerIn one published case, surgery followed the outpatient visit the next day. Explore more treatment optionsApproved medicines and research may open different paths for specific lung-cancer subtypes. Assess surgery that may preserve lung functionA multidisciplinary plan can change the treatment sequence and the extent of surgery.

Find treatment options that fit your goal.

Explore specialist care, procedures and research relevant to this condition in Shanghai. Your treating team must confirm what is suitable for you.

Move toward treatment sooner

In one published case, surgery followed the outpatient visit the next day.

Explore treatment options

Outpatient tests, then surgery the following day

A 2019 Shanghai Pulmonary Hospital case describes a patient whose tests were completed as an outpatient and who underwent surgery the next day after being judged eligible for day surgery. This was an individual case, not a guaranteed schedule; preparation, eligibility and appointment timing must be confirmed with the hospital.

View original source

Explore more treatment options

Approved medicines and research may open different paths for specific lung-cancer subtypes.

Explore treatment options

An approved indication and a registered drug study

China approved an ivonescimab combination in 2024 for a defined group of non-squamous NSCLC patients after EGFR-targeted treatment; a Shanghai Pulmonary Hospital investigator is also listed in an early HER3-ADC study. Your tumour type, prior treatments and current study availability determine whether either is relevant.

View original source View original source

Assess surgery that may preserve lung function

A multidisciplinary plan can change the treatment sequence and the extent of surgery.

Explore treatment options

Complex surgery after team review

A Xinhua Hospital case describes sleeve resection and airway reconstruction after treatment before surgery; an East Hospital case describes chemotherapy plus immunotherapy followed by minimally invasive lobectomy after multidisciplinary review. These cases show possible approaches, not a promise that another patient can avoid pneumonectomy or have the same outcome.

View original source View original source

Treatment choices, eligibility and timing require an individual assessment by the hospital's clinical team.

Choose a hospital with the right expertise.

Start with each specialty's standing, then see the specific care it offers for this condition. Shanghai Chest Hospital, Shanghai Pulmonary Hospital

Clinical cases, services and research are identified separately. Published material does not confirm current availability or individual eligibility.

Care planning

Tell us what care you are looking for. We can help you understand hospital options, document requirements and travel arrangements.

Turn your treatment goal into a clear next step.

Before your visit

Organise existing test results and questions

When planning

Understand hospital locations, costs and appointment timing

After arriving in China

Translation and care coordination as agreed

The initial service consultation is free. Hospital care and any subsequent paid services are explained separately.

Records to prepare

Start with the records you already have. Your treating doctor will decide whether further tests are needed.

Lung cancer

  • Pathology and existing molecular or biomarker reports
  • Chest CT and completed staging images in original format
  • Previous treatment, breathing tests if available and current symptoms

Further reading

Explore the diagnosis, possible care paths and questions to ask your treating team.

NSCLC Molecular Reports: Preparing a Treatment Review in Shanghai
Does a gene mutation mean the cancer is inherited?

Not necessarily. Many tumour changes are acquired and are not passed to children. If the report raises a possible inherited finding, clinicians may recommend separate confirmatory testing and genetic counselling. A tumour report alone should not be used to label relatives at risk. View original source

Is the largest testing panel always the best choice?

No universal panel is best for every decision. The relevant markers, available sample, test quality and how a result would affect care matter. Ask what the proposed test adds to the existing report and whether it will answer an unresolved clinical question. View original source

Does a trial mentioned in a report guarantee a place in Shanghai?

No. Recruitment, eligibility, location and practical arrangements must be checked with the trial team. A historical research publication or a report-generated trial suggestion is not an appointment, an eligibility decision or a promise of benefit. Ask the Shanghai lung-cancer team to review the full report and treatment history and explain the standard treatment and testing options relevant now. View original source View original source

Turn your treatment goal into a clear next step.

Tell us what care you are looking for. We can help you understand hospital options, document requirements and travel arrangements.

The initial service consultation is free. Hospital care and any subsequent paid services are explained separately.Treatment choices, eligibility and timing require an individual assessment by the hospital's clinical team.

Contact us

Your message opens in WhatsApp or your email app for you to review before sending. Please do not include a full medical record in the first message.

Contact us on WhatsApp Contact us by email
Sources and editorial notes

See the original sources behind the clinical and hospital information on this page.

  1. Tongji University, 2019 day-surgery case

    View original source

  2. China National Healthcare Security Administration, 2024 indication documents

    View original source

  3. ClinicalTrials.gov, NCT06298058

    View original source

  4. Shanghai Jiao Tong University School of Medicine, 2026 surgery case

    View original source

  5. Xinmin Evening News, 2024 multidisciplinary case

    View original source

  6. Fudan hospital specialty reputation ranking, 2023

    View original source

  7. Shanghai Jiao Tong University School of Medicine, Shanghai Chest Hospital

    View original source

  8. Shanghai Pulmonary Hospital, 2023 thoracic surgery activity

    View original source

  9. NCI: Non-Small Cell Lung Cancer Treatment

    View original source

  10. NCI: Biomarker Testing for Cancer Treatment

    View original source

  11. Tongji University: Shanghai Pulmonary Hospital thoracic research team

    View original source

  12. Shanghai Jiao Tong University School of Medicine: Shanghai Chest Hospital oncology research

    View original source

Further reading

NSCLC Molecular Reports: Preparing a Treatment Review in Shanghai
See hospital expertiseContact us